RAINBOW CHILDREN'S MEDICARE LIMITED Financials Rainbow Children's Medicare Limited
Equities
RAINBOW
INE961O01016
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,375 INR | +0.96% |
|
+5.98% | +15.27% |
| Mar. 18 | Rainbow Children's Medicare Limited Approves Appointment of Adarsh Kancharla as Non-Executive Director | CI |
| Mar. 08 | Rainbow Children's Medicare Expands Capacity of Hyderabad, India Hospital | MT |
Valuation
| Fiscal Period: March | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 74,147 | 139,585 | - | - |
| Enterprise Value (EV) 1 | 79,395 | 145,301 | 144,123 | 143,286 |
| P/E ratio | 35 x | 61.9 x | 50.9 x | 40.4 x |
| Yield | 0.41% | 0.27% | 0.33% | 0.42% |
| Capitalization / Revenue | 6.32 x | 10.6 x | 8.79 x | 7.4 x |
| EV / Revenue | 6.77 x | 11.1 x | 9.08 x | 7.59 x |
| EV / EBITDA | 60.3 x | 33.6 x | 27.9 x | 23 x |
| EV / FCF | 42.7 x | 272 x | 87.7 x | 65.3 x |
| FCF Yield | 2.34% | 0.37% | 1.14% | 1.53% |
| Price to Book | 7 x | 11.1 x | 9.3 x | 7.74 x |
| Nbr of stocks (in thousands) | 101,502 | 101,502 | - | - |
| Reference price 2 | 730.5 | 1,375 | 1,375 | 1,375 |
| Announcement Date | 5/14/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net sales 1 | - | 11,736 | 13,107 | 15,880 | 18,869 |
| EBITDA 1 | - | 1,316 | 4,330 | 5,163 | 6,232 |
| EBIT 1 | - | 413.2 | 3,416 | 4,089 | 5,037 |
| Operating Margin | - | 3.52% | 26.06% | 25.75% | 26.7% |
| Earnings before Tax (EBT) 1 | - | 169.9 | 3,005 | 3,575 | 4,469 |
| Net income 1 | 1,383 | 2,108 | 2,277 | 2,729 | 3,431 |
| Net margin | - | 17.97% | 17.37% | 17.19% | 18.18% |
| EPS 2 | 14.45 | 20.89 | 22.22 | 27.03 | 34.01 |
| Free Cash Flow 1 | - | 1,859 | 534.5 | 1,642 | 2,193 |
| FCF margin | - | 15.84% | 4.08% | 10.34% | 11.62% |
| FCF Conversion (EBITDA) | - | 141.3% | 12.35% | 31.81% | 35.19% |
| FCF Conversion (Net income) | - | 88.19% | 23.48% | 60.18% | 63.92% |
| Dividend per Share 2 | - | 3.000 | 3.746 | 4.592 | 5.783 |
| Announcement Date | 5/27/22 | 5/14/23 | - | - | - |
1INR in Million2INR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: Marzo | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 3,131 | 3,064 | 3,170 | 2,872 | 3,511 | 3,309 | 3,269 |
| EBITDA 1 | 1,093 | 1,068 | 980.1 | 877 | 1,149 | 1,122 | 994.5 |
| EBIT 1 | - | - | 752.8 | 623.8 | 813 | 856 | 674 |
| Operating Margin | - | - | 23.75% | 21.72% | 23.16% | 25.87% | 20.62% |
| Earnings before Tax (EBT) 1 | - | - | - | 556.2 | 756 | 801 | 613 |
| Net income 1 | 615.1 | - | - | 410 | 623 | 605.8 | 449 |
| Net margin | 19.65% | - | - | 14.28% | 17.75% | 18.31% | 13.74% |
| EPS 2 | - | - | - | 4.040 | 5.700 | 6.100 | 4.400 |
| Dividend per Share | - | - | - | - | - | - | - |
| Announcement Date | 11/3/22 | 2/9/23 | 5/14/23 | 8/7/23 | - | - | - |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: Marzo | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|
| Net Debt 1 | - | 5,248 | 5,716 | 4,538 | 3,701 |
| Net Cash position 1 | - | - | - | - | - |
| Leverage (Debt/EBITDA) | - | 3.988 x | 1.32 x | 0.879 x | 0.5938 x |
| Free Cash Flow 1 | - | 1,859 | 535 | 1,643 | 2,193 |
| ROE (net income / shareholders' equity) | - | 25.4% | 19.1% | 19.6% | 20.5% |
| ROA (Net income/ Total Assets) | - | 13.7% | 11.6% | 12.2% | 13.7% |
| Assets 1 | - | 15,360 | 19,682 | 22,460 | 25,095 |
| Book Value Per Share 2 | - | 104.0 | 124.0 | 148.0 | 178.0 |
| Cash Flow per Share 2 | - | 32.40 | 30.80 | 38.40 | 48.50 |
| Capex 1 | - | 1,413 | 2,947 | 2,419 | 2,452 |
| Capex / Sales | - | 12.04% | 22.48% | 15.24% | 12.99% |
| Announcement Date | 5/27/22 | 5/14/23 | - | - | - |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
C-
Sell
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,375
INR
Average target price
1,398
INR
Spread / Average Target
+1.65%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.27% | 1.67B | |
| -18.46% | 16.57B | |
| +4.50% | 12.4B | |
| +4.98% | 11.69B | |
| +4.26% | 10.24B | |
| -2.97% | 7.76B | |
| +20.21% | 7.17B | |
| +6.45% | 6.74B | |
| +50.68% | 4.65B | |
| -5.12% | 4.25B |
- Stock Market
- Equities
- RAINBOW Stock
- Financials Rainbow Children's Medicare Limited
